Publication: Phenylbutyrate, a histone deacetylase inhibitor, protects against Adriamycin-induced cardiac injury
3
Issued Date
2007-06-15
Resource Type
ISSN
08915849
Other identifier(s)
2-s2.0-34248591511
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Free Radical Biology and Medicine. Vol.42, No.12 (2007), 1818-1825
Suggested Citation
Chotiros Daosukho, Yumin Chen, Teresa Noel, Pradoldej Sompol, Ramaneeya Nithipongvanitch, Joyce M. Velez, Terry D. Oberley, Daret K. St. Clair Phenylbutyrate, a histone deacetylase inhibitor, protects against Adriamycin-induced cardiac injury. Free Radical Biology and Medicine. Vol.42, No.12 (2007), 1818-1825. doi:10.1016/j.freeradbiomed.2007.03.007 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/24182
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Phenylbutyrate, a histone deacetylase inhibitor, protects against Adriamycin-induced cardiac injury
Other Contributor(s)
Abstract
Cardiac injury is a major complication for oxidative-stress-generating anticancer agents exemplified by Adriamycin (ADR). Recently, several histone deacetylase inhibitors (HDACIs) including phenylbutyrate (PBA) have shown promise in the treatment of cancer with little known toxicity to normal tissues. PBA has been shown to protect against oxidative stress in normal tissues. Here, we examined whether PBA might protect heart against ADR toxicity in a mouse model. The mice were i.p. injected with ADR (20 mg/kg). PBA (400 mg/kg/day) was i.p. injected 1 day before and daily after the ADR injection for 2 days. We found that PBA significantly decreased the ADR-associated elevation of serum lactate dehydrogenase and creatine kinase activities and diminished ADR-induced ultrastructual damages of cardiac tissue by more than 70%. Importantly, PBA completely rescued ADR-caused reduction of cardiac functions exemplified by ejection fraction and fraction shortening, and increased cardiac manganese superoxide dismutase (MnSOD) protein and activity. Our results reveal a previously unrecognized role of HDACIs in protecting against ADR-induced cardiac injury and suggest that PBA may exert its cardioprotective effect, in part, by the increase of MnSOD. Thus, combining HDACIs with ADR could add a new mechanism to fight cancer while simultaneously decrease ADR-induced cardiotoxicity. © 2007 Elsevier Inc. All rights reserved.